SCHEMBL1928760

SCHEMBL1928760

O=C(O)c1cc(Br)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15228733 0.79 — —
SCHEMBL14413703 0.79 — —
SCHEMBL15176658 0.79 — —
SCHEMBL27341789 0.76 PKM (0.54) —
SCHEMBL23718091 0.74 CREBBP (1.00) —
SCHEMBL519390 0.74 CREBBP (0.61) —
SCHEMBL31666875 0.74 CREBBP (0.56) —
SCHEMBL23952430 0.74 CREBBP (0.67) —
SCHEMBL16501051 0.74 CREBBP (0.56) —
SCHEMBL1518124 0.74 ALDH1A1 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119330867-A Pyrrole amide derivative, preparation method thereof and beta-type pyrrole amide derivative2Use of allosteric antagonists of adrenergic receptors 常州大学 2025-01-21 — — CN claimed
US-20260137698-A1 CYCLIN-DEPENDENT KINASE 7 INHIBITORS JOINT STOCK CO «BIOCAD» (RU) 2026-05-21 — — US disclosed
CN-120904170-A Preparation method, intermediate and application of membranous element 上海陶术生物科技股份有限公司 2025-11-07 — — CN disclosed
US-RE50527-E1 Covalent inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2025-08-12 — — US disclosed
EP-4592283-A1 CYCLIN-DEPENDENT KINASE 7 INHIBITORS Joint Stock Company "Biocad" (RU) 2025-07-30 — — EP disclosed
EP-4405334-B1 SORTILIN INHIBITORS SORTINA PHARMA AB (SE) 2025-02-12 — — EP disclosed
CN-119330867-A Pyrrole amide derivative, preparation method thereof and beta-type pyrrole amide derivative2Use of allosteric antagonists of adrenergic receptors 常州大学 2025-01-21 — — CN disclosed
US-20250002460-A1 SORTILIN INHIBITORS SORTINA PHARMA AB (SE) 2025-01-02 — — US disclosed
CN-118684662-A Pyrrolopyridone-containing compounds 正大天晴药业集团股份有限公司 2024-09-24 — — CN disclosed
US-20240254134-A1 AGELASTATIN A DERIVATIVES AND RELATED METHODS BAYLOR UNIVERSITY (US) 2024-08-01 — — US disclosed
US-20070185097-A1 MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY 2007-08-09 — — US disclosed
WO-2007005531-A2 ALKENYLDIARYLMETHANES, FUSED ANALOGS AND SYNTHESES THEREOF PURDUE RESEARCH FOUNDATION (US) 2007-01-11 — — WO disclosed
WO-2006123257-A2 PHENYL-3-{(3-(1H-PYRROL-2-YL)-[1, 2 , 4]0XADIAZ0L-5-YL]PIPERIDIN-1-YL}-METHANONE DERIVATIVES AND RELATED COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2006-11-23 — — WO disclosed
US-7006921-B1 Method for accurately estimating pKa of molecules using atom type definitions and partial least squares TRIPOS, L.P. 2006-02-28 — — US disclosed
US-4588817-A Antibiotic nodusmicins THE UPJOHN COMPANY (US) 1986-05-13 — — US disclosed
US-4461903-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1984-07-24 — — US disclosed
US-4448970-A ANTIBIOTICS, BACTERICIDES THE UPJOHN COMPANY (US) 1984-05-15 — — US disclosed
US-4363922-A Esters of antibiotic nodusmicin THE UPJOHN COMPANY (US) 1982-12-14 — — US disclosed
US-4360683-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1982-11-23 — — US disclosed
US-4351769-A Antibiotic composition of matter THE UPJOHN COMPANY (US) 1982-09-28 — — US disclosed
Send feedback